Cleveland BioLabs [CBLI] has received a potential $8.9 million contract from the Defense Department's Chemical Biological Medical Systems (CBMS) Joint Program Management Office for the advanced development of Protectan CBLB502 as a medical radiation countermeasure to treat radiation injury following exposure to radiation from nuclear or radiological weapons. Earlier this year Osiris Therapeutics [OSIR] won a potential $225 million contract from DoD to develop its Prochymal adult stem therapy for the repair of gastrointestinal injury due to radiation exposure (TR2,…
Recommended
Trending
Congress Updates
Warren And Sheehy Renew Call for “Right to Repair” In NDAA
Sen. Elizabeth Warren (D-Mass.) and Sen. Timothy Sheehy (R-Mont.), two members of the Senate Armed Services Committee (SASC), are renewing their call for “Right to Repair” language in the National […]
HASC Looks To Restrict USV Deliveries Without Navy CONOPS And Strategy
The House Armed Services Committee’s (HASC) fiscal year 2027 defense policy draft bill aims to restrict the Navy’s use of unmanned surface vessels (USV) until it decides on key factors […]
Gaps In Army’s Tactical Counter-Drone Capabilities Remain Concern Of HASC
A draft defense policy bill released this week says the Army is fielding counter-drone capabilities for defense of fixed sites and maneuver forces but suggests that troops at the lowest […]
HASC Wants Closer Look At Army’s SBMC Program, Cites Avoiding Past IVAS Missteps
The House Armed Services Committee (HASC) wants a closer look at the Army’s Soldier Borne Mission Command (SBMC) effort, citing support for the development program while expressing caution to avoid […]